IBM Alpha Zone News
9 articles
Israeli startup claims blueprint for million-qubit machine in single cryostat, challenging Google and IBM.
QuamCore, an Israeli deep-tech startup, has raised $26 million in a Series A funding round to advance its development of a million-qubit quantum processor. The funding, which includes a $4 million non-dilutive grant from the Israel Innovation Authority, brings the companys total funding to $35 million. The Series A was led by Sentinel Global, with participation from Arkin Capital and other investors. QuamCore aims to overcome the scaling challenges in quantum computing by redesigning the architecture of superconducting qubits, embedding digital control logic within the cryostat. This approach reduces thermal load and facilitates large-scale operation. The company plans to move from simulation to fabrication of its processors, establish a quantum lab, and expand its operations.
Investment
לדבריו של יזם הסייבר, שלמה קרמר, רכישת סייברארק מסמלת את סיום תקופת הצמיחה של אחת המתחרות הגדולות שלו, ותחילתה של דרך איטית ושמרנית יותר עבורה
The article discusses the acquisition of CyberArk by Palo Alto Networks, a major player in the cybersecurity industry. Shlomo Kramer, a prominent figure in the cybersecurity field and founder of Cato Networks, criticizes the acquisition, suggesting it marks the end of Palo Altos growth phase and the beginning of a more conservative path similar to IBMs. Kramer argues that the future of identity management lies in non-human identities, such as APIs and AI systems. He also criticizes Palo Altos platform integration strategy, claiming it lacks true cloud architecture. The acquisition is seen as a strategic move by Palo Alto, but Kramers comments suggest potential challenges ahead.
Acquisition
The Cato Networks CEO and co-founder of Check Point compares Palo Alto’s ambitions to IBM’s decline and warns AI will disrupt identity management.
The article discusses the acquisition of CyberArk by Palo Alto Networks for $25 billion, a move criticized by cybersecurity veteran Shlomo Kramer. Kramer, a co-founder of several cybersecurity firms, argues that the acquisition marks the end of a successful era for Palo Alto Networks, likening it to IBMs strategy of platformization. He suggests that the acquisition may not be beneficial, as no pure-play cybersecurity vendor has successfully managed multi-platform operations. Additionally, Kramer criticizes CyberArks focus on human identity, suggesting that non-human identity will become more significant due to emerging API and AI threats. The article also references similar criticisms from other industry leaders.
Acquisition
The IBM z17 mainframe can process 450 billion AI inferences a day, a significant step up from what its predecessor could.
IBM has announced the release of its latest mainframe hardware, the IBM z17, which is designed to accelerate AI adoption. The z17, powered by the IBM Telum II processor, supports over 250 AI use cases and can process 450 billion inference operations per day, a 50% increase over its predecessor. The mainframe is designed to integrate with other hardware and software, and it includes 48 IBM Spyre AI accelerator chips, with plans to increase to 96 within a year. The z17 is more energy-efficient and adaptable to future AI developments. It will be generally available on June 18.
Product StageCustomers
הסטארט-אפים שמנורה מבטחים ו-IBM בחרו לאקסלרטור
Menora Mivtachim and IBM have selected 12 Israeli startups for the Alpha Zone acceleration program. The chosen startups, which were selected from around 100 applicants, will receive technological and business guidance from Menora Mivtachim and seven international insurance companies, as well as technology experts from IBM around the world. They will also receive workspace at IBM and a credit for IBM cloud services worth up to $120,000 per year. In addition, the selected startups will have the opportunity to conduct feasibility tests at Menora Mivtachim and the seven participating international insurance companies, and the chance to receive investment from the insurance companies.
PartnersInvestment
Hadassah, IBM set up digital health accelerator
IBM Israel and Hadassah Medical Center in Jerusalem have announced the establishment of a special accelerator for startups in digital medicine. The accelerator, to be built by the LR group on the premises of the Biohouse technology incubator, will provide companies with easy access to hospital resources and technological assistance. IBM will offer technological advice and free access to its advanced tools. The program aims to advance medical innovation and development for the treatment of patients at Hadassah and other hospitals worldwide. The accelerator is scheduled to begin in the first quarter of 2019.
PartnersExpand
Menorah Mivtachim teams with IBM accelerator
Menorah Mivtachim Holdings Ltd. is partnering with IBMs Alpha Zone accelerator to enter the insurtech market. The two companies will jointly select advanced-stage Israeli insurtech startups for the Alpha Zone accelerator program. Selected startups will receive insurance consultation, access to big data from Menorah Mivtachim, and technological and business assistance from IBM. Menorah Mivtachims step reflects the growing importance of digitalization and technology in the insurance sector. Other insurance companies, such as AIG and AXA, have also shown interest in Israeli insurtech startups.
Partners
U.K., IBM, Launch Israel-Based Healthcare Technology Accelerator
The U.K. and IBM have launched the U.K. Israel Dangoor Health Initiative, a program that aims to encourage digital health startups to integrate their technologies into the U.K.s National Health Service (NHS). The program is operated by IBM Alpha Zone and supported by DigitalHealth.London, connecting innovators with health organizations in the U.K. Two to three startups will be admitted each semester for a period of two years, receiving technical support, mentorship, and guidance. The program is funded by British businessman and philanthropist David Dangoor. The initiative was launched at an event attended by 150 guests from the Israeli digital health and biotech community.
Partners
New Israel accelerator IBM's first anywhere
IBM is set to open its first accelerator in Israel, called IBM Alpha Zone. The accelerator will allow IBM to build deeper relationships with start-ups and take advantage of Israels start-up culture. The program will focus on innovative technology and last for 24 weeks. IBM will provide access to developers to help start-ups develop their products. Once the products are developed, they will be showcased to IBM customers worldwide. IBM is partnering with Ziontech Blue, an angel investment fund, to provide the business development component. The accelerator will not retain any equity in the start-ups or charge any money. The first round of candidates is currently being recruited.
Partners